Therapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat?

The advent of triple therapy (TT) with first-generation protease inhibitors boceprevir (BOC) and telaprevir (TVR) in addition to pegylated interferon and ribavirin resulted in a significant gain in terms of sustained virological response (SVR) when treating naive or previous treated patients with ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Petta, Salvatore, Craxì, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495629/
https://www.ncbi.nlm.nih.gov/pubmed/23173606
http://dx.doi.org/10.1186/1471-2334-12-S2-S3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495629/
https://www.ncbi.nlm.nih.gov/pubmed/23173606
http://dx.doi.org/10.1186/1471-2334-12-S2-S3

Ejemplares similares